Search results
Carpal tunnel syndrome: Early signs and what to do
Medical News Today· 6 days agoIn carpal tunnel syndrome (CTS), the median nerve becomes squeezed as it passes a narrow passageway that the bones and ligaments form in the wrist. A...
Law enforcement seen outside Longview medical practice of murder suspect’s son
KETK Tyler via Yahoo News· 4 days agoLONGVIEW, Texas (KETK) – An increased police presence was seen Thursday morning at the rheumatology...
Law enforcement surrounds Longview doctor's office belonging to son of suspect in Horaney murder
The Longview News-Journal· 4 days agoVehicles from the Texas Department of Public Safety and Gregg County Sheriff's Office are parked...
New Therapeutic Promise For Fibromyalgia
Forbes· 20 hours agoA novel approach using a non-invasive, painless laser called Fibrolux offers new hope for fibromyalgia, a notoriously challenging condition that affects...
New facility in Paramus brings health care 'outside the four walls of the hospital'
The Bergen Record via Yahoo News· 5 days agoSo far, orthopedics, allergy, neuroscience, primary care, rheumatology, cardiology, nephrology,...
Publications name ‘Top Doctors’ at L+M, Westerly hospitals
The Day· 5 days agoEighteen physicians affiliated with Lawrence + Memorial and Westerly hospitals have been recognized as 2024 Top Doctors by Connecticut Magazine and Rhode Island Monthly. Connecticut ...
Updated Sjögren Disease Guideline Takes New Approach, Format
Medscape· 6 days agoAn updated guideline from the British Society for Rheumatology (BSR) on the management of Sjögren...
Reasons for Heightened Thrombotic Risk in RA Remain Unclear
Medscape· 7 days agoPeople with rheumatoid arthritis (RA) have a consistently higher risk for venous thromboembolism (VTE) than the general population, but the reasons for this remain unclear, research presented ...
The U.S. Food & Drug Administration (FDA) Approves Updated LUPKYNIS® (voclosporin) Label to include...
Morningstar· 7 days agoThe U.S. Food & Drug Administration (FDA) Approves Updated LUPKYNIS® (voclosporin) Label to include Long-Term Data from the AURORA Clinical Program New data showing sustained complete renal response with LUPKYNIS through three years Monthly kidney
Reviews Cross-Journal Editorial Team
Nature· 2 days agoReviews Cross-Journal Editorial Team